A total of 216 patients with complete information, including gender, age, clinical stage, tumor grade, T stage, platelet content, albumin content, alpha‐fetoprotein (AFP) content, as well as vascular invasion, were enrolled into the TCGA HCC cohort. This evidence concerns the gene ALB and hepatocellular carcinoma.